首页> 外文学位 >Profiling cellular protein expression in H-Ras mediated oncogenic transformation by functional proteomics.
【24h】

Profiling cellular protein expression in H-Ras mediated oncogenic transformation by functional proteomics.

机译:通过功能蛋白质组学分析H-Ras介导的致癌转化中的细胞蛋白表达。

获取原文
获取原文并翻译 | 示例

摘要

H-Ras plays a critical role in the transformation of cells. To further understand the mechanism of H-Ras mediated oncogenic transformation, we utilized an ovarian epithelial transformation model in which H-RasV12 was the primary transforming agent to study systematically the protein changes that occur following transformation. Using 2-D gel proteomic analysis, we identified 32 proteins significantly altered in human ovarian epithelial cells transformed by H-RasV12 (T29H). These proteins are grouped into several functional classes, including antioxidant proteins, metabolic enzymes, proteins involved in DNA/protein methylation, calcium binding/signaling proteins, and apoptotic proteases. The changes in protein expression identified in our proteomic study occurred at both transcriptional and posttranscriptional levels. For example, methionine adenosyl transferase (MAT2A) was up-regulated transcriptionally and may affect H-Ras activity in a positive feedback loop; whereas caspase 4 was altered post-translationally by H-Ras and may affect T29H resistance to apoptosis.; We have also identified several antioxidant enzymes positively regulated by H-Ras transformation. These enzymes make up the second largest group of proteins identified in T29H cells and include selenophosphate synthetase, peroxiredoxin III and IV, and NADH dehydrogenase ubiquinone. Given the number of antioxidant proteins affected, we hypothesized that H-Ras mediated resistance against free radical induced apoptosis to protect cancer cells from higher levels of endogenous oxidative stress. When challenged with H2O 2, we discovered that T29H cells were indeed resistant to H2O 2 mediated apoptosis. This effect was clearly linked to H-Ras signaling, as suppressing H-Ras signaling pathways by small molecule inhibitors and siRNAs eliminated the protective effect. We propose that these enzymes participate in a mechanism whereby H-Ras up-regulate antioxidant enzymes to overcome oxidative stresses mediated by increased metabolic loads in the tumor microenvironment.; We further revealed that the tumor susceptibility protein 101 (TSG101) was up-regulated post-translationally by H-Ras through the Raf/MEK/ERK kinase signaling axis, and this up-regulation was dependent on H-Ras activity. Transient TSG101 gene silencing using siRNA decreased cell proliferation, arrested cells at G2/M, led to cellular apoptosis, and suppressed tumor formation in nude mice. These results demonstrated that TSG101 is an important down-stream effector of Ras and involved in maintenance of tumor growth in human ovarian cancer.
机译:H-Ras在细胞转化中起关键作用。为了进一步了解H-Ras介导的致癌转化的机制,我们利用了以H-RasV12为主要转化剂的卵巢上皮转化模型,系统地研究了转化后发生的蛋白质变化。使用2-D凝胶蛋白质组学分析,我们鉴定了H-RasV12(T29H)转化的人卵巢上皮细胞中32个蛋白质的显着改变。这些蛋白质分为几个功能类别,包括抗氧化剂蛋白质,代谢酶,DNA /蛋白质甲基化所涉及的蛋白质,钙结合/信号传导蛋白质和凋亡蛋白酶。在蛋白质组学研究中确定的蛋白质表达变化发生在转录和转录后水平。例如,蛋氨酸腺苷转移酶(MAT2A)在转录上被上调,并可能在正反馈回路中影响H-Ras活性。 Caspase 4在翻译后被H-Ras改变,可能影响T29H对细胞凋亡的抵抗力。我们还发现了由H-Ras转化正调控的几种抗氧化酶。这些酶构成了在T29H细胞中鉴定出的第二大蛋白质组,包括硒磷酸合成酶,过氧化物酶III和IV,以及NADH脱氢酶泛醌。考虑到受影响的抗氧化剂蛋白的数量,我们假设H-Ras介导的对自由基的抗性诱导了细胞凋亡,以保护癌细胞免受更高水平的内源性氧化应激的侵害。当受到H2O 2攻击时,我们发现T29H细胞确实对H2O 2介导的细胞凋亡具有抗性。这种作用显然与H-Ras信号传导有关,因为通过小分子抑制剂和siRNA抑制H-Ras信号传导途径消除了保护作用。我们建议这些酶参与一种机制,其中H-Ras上调抗氧化酶以克服肿瘤微环境中代谢负荷增加所介导的氧化应激。我们进一步揭示,肿瘤易感蛋白101(TSG101)在翻译后被H-Ras通过Raf / MEK / ERK激酶信号转导上调,而这种上调取决于H-Ras的活性。使用siRNA进行的瞬时TSG101基因沉默可降低细胞增殖,将细胞停滞在G2 / M,导致细胞凋亡,并抑制裸鼠的肿瘤形成。这些结果表明,TSG101是Ras的重要下游效应器,参与维持人类卵巢癌的肿瘤生长。

著录项

  • 作者

    Young, Travis Warren.;

  • 作者单位

    The University of Texas Graduate School of Biomedical Sciences at Galveston.;

  • 授予单位 The University of Texas Graduate School of Biomedical Sciences at Galveston.;
  • 学科 Health Sciences Oncology.; Health Sciences Pharmacology.; Biology Molecular.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 96 p.
  • 总页数 96
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;药理学;分子遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号